| 1 |
angiotensin-converting enzyme 2
(2870 times)
|
Medicine
(261 times)
|
SARS-CoV-2 (851 times)
COVID-19 (710 times)
RAS (342 times)
|
2002 Angiotensin-converting enzyme 2 is an essential regulator of heart function.
|
| 2 |
Ang-converting enzyme 2
(8 times)
|
Physiology
(2 times)
|
Ang (4 times)
Ang II (2 times)
RAS (2 times)
|
2009 Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus.
|
| 3 |
angiotensin-converting enzyme-related carboxypeptidase 2
(4 times)
|
Water-Electrolyte Imbalance
(2 times)
|
Ang II (2 times)
AhR (1 time)
Ang (1 time)
|
2010 Maternal apelin physiology during rat pregnancy: the role of the placenta.
|
| 4 |
ACE type 2
(3 times)
|
Physiology
(2 times)
|
ACE (2 times)
Ang 1-7 (2 times)
Ang II (2 times)
|
2012 Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.
|
| 5 |
ACE2 KI mice
(1 time)
|
Neurology
(1 time)
|
BLA (1 time)
EPM (1 time)
MasR (1 time)
|
2016 Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors.
|
| 6 |
ACE2-Fc
(1 time)
|
|
RBDs (1 time)
SARS-CoV-2 (1 time)
|
2020 Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2.
|
| 7 |
ACE2-gene network
(1 time)
|
|
---
|
2020 ACE2 Netlas: In-silico functional characterization and drug-gene interactions of ACE2 gene network to understand its potential involvement in COVID-19 susceptibility.
|
| 8 |
ACE2/rMAS gene expression compared to the HF group
(1 time)
|
Gastrointestinal Diseases
(1 time)
|
ACE (1 time)
Ang II (1 time)
AT1r (1 time)
|
2019 Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model.
|
| 9 |
AGS-ACE2
(1 time)
|
Microbiology
(1 time)
|
AGS (1 time)
CG (1 time)
RBD (1 time)
|
2021 Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors.
|
| 10 |
Altimeter Corrected Elevations 2
(1 time)
|
Environmental Health
(1 time)
|
GDEM (1 time)
|
2011 Evaluation of the differences between the SRTM and satellite radar altimetry height measurements and the approach taken for the ACE2 GDEM in areas of large disagreement.
|
| 11 |
analyses, in male subjects the model of rs2106809
(1 time)
|
Endocrinology
(1 time)
|
RAS (1 time)
|
2010 Interactions among related genes of renin-angiotensin system associated with type 2 diabetes.
|
| 12 |
Ang converting enzyme type 2
(1 time)
|
Medicine
(1 time)
|
ACh (1 time)
Ang (1 time)
AP (1 time)
|
2018 Central administration of TRV027 improves baroreflex sensitivity and vascular reactivity in spontaneously hypertensive rats.
|
| 13 |
Angiotensin Converting Enzyme 2 Activity in Biological Fluid
(1 time)
|
Molecular Biology
(1 time)
|
ADAM-17 (1 time)
Ang (1 time)
CVs (1 time)
|
2017 Measurement of Angiotensin Converting Enzyme 2 Activity in Biological Fluid (ACE2).
|
| 14 |
antiotensin-converting enzyme homologue 2
(1 time)
|
Medicine
(1 time)
|
AT1R (1 time)
DMN (1 time)
ERK (1 time)
|
2020 Fugan Wan alleviates hepatic fibrosis by inhibiting ACE/Ang II/AT-1R signaling pathway and enhancing ACE2/Ang 1-7/Mas signaling pathway in hepatic fibrosis rat models.
|
| 15 |
same cell entry receptor as SARS-CoV,angiotensin-converting enzyme 2
(1 time)
|
Biology
(1 time)
|
SARS-CoV-2 (1 time)
|
2020 Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.
|
| 16 |
SARS-CoV-2-angiotensin-converting enzyme 2
(1 time)
|
Genetics
(1 time)
|
DEG (1 time)
|
2021 Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age.
|
| 17 |
system-RAAS-Angiotensin converting enzyme 2
(1 time)
|
Biology
(1 time)
|
ARDS (1 time)
CD147 (1 time)
COVID-19 (1 time)
|
2020 Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients.
|
A Search Service for Abbreviation / Long Form